Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S12-S21. doi: 10.1093/jpids/pix053.

Abstract

Invasive fungal diseases (IFDs) are devastating opportunistic infections that result in significant morbidity and death in a broad range of pediatric patients, particularly those with a compromised immune system. Recognizing them can be difficult, because nonspecific clinical signs and symptoms or isolated fever are frequently the only presenting features. Therefore, a high index of clinical suspicion is necessary in patients at increased risk of IFD, which requires knowledge of the pediatric patient population at risk, additional predisposing factors within this population, and the clinical signs and symptoms of IFD. With this review, we aim to summarize current knowledge regarding the recognition and clinical presentation of IFD in neonates and children.

Keywords: clinical presentation; invasive aspergillosis; invasive candidiasis; invasive fungal disease; pediatric patients.

Publication types

  • Review

MeSH terms

  • Aspergillosis / diagnosis
  • Candidiasis / diagnosis
  • Child
  • Critical Illness
  • Cross Infection / diagnosis
  • Cross Infection / microbiology
  • Hematologic Neoplasms / complications
  • Hospitalization
  • Humans
  • Immunocompromised Host
  • Immunologic Deficiency Syndromes / complications
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / diagnosis
  • Intensive Care Units, Pediatric
  • Invasive Fungal Infections / diagnosis*
  • Mucormycosis / diagnosis
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / microbiology
  • Risk Factors
  • Transplant Recipients